Biased dependency of CD80 versus CD86 in the induction of transcription factors regulating the human IL-2 promoter

International Immunology

Volumn 10, Issue 4, 1998, Pages 499-506

  Olsson, Christina ^a   Michaëlsson, Erik ^a   Parra, Eduardo ^a,b   Pettersson, Ulrika ^a   Lando, Peter A ^a   Dohlsten, Mikael ^b  

^a Pharmacia & Upjohn AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Co stimulatory molecules; Human T lymphocytes; Superantigens; Transcription factors

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; CHO CELL; ENHANCER REGION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CHO CELLS; CRICETINAE; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; SUPERANTIGENS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0031896336     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.4.499     Document Type: Article

References (55)

1. Janeway, C. A. 1989. Immunogenicity signals 1, 2, 3... and 0. Immunol. Today 10:283.
2. Liu, Y. and Linsley, P. S. 1992. Co-stimulation of T cell growth. Curr. Opin. Immunol. 4:265.
3. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
4. Janeway, C. A., Jr and Bottomly, K. 1994. Signals and signs for lymphocyte responses. Cell 76:275.
5. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. and Allison, J. P. 1992. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356:607.
6. Linsley, P. S. and Ledbetter, J. A. 1993. The role of CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
7. + T cells. J. Exp. Med. 173:759.
8. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K. and Ledbetter, J. A. 1991. Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
9. Gross, J. A., Callas, E. and Alison, J. P. 1992. Identification and distribution of the co-stimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
10. Linsley, P. S., Clark, E. A. and Ledbetter, J. A. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB1. Proc. Natl Acad. Sci. USA 87:5031.
11. Hatchcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P. and Modes, R. J. 1993. Identification of an alternative CTLA-4 ligand co-stimulatory for T cell activation. Science 262:905.
12. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo V. A., Jr, Lombard, L. A., Gray, G. S. and Nadler, L. M. 1993. Cloning of B7-2: a CTLA-4 counter receptor that co-stimulates human T cell proliferation. Science 262:909.
13. Larsen, C. P., Ritchie, S. C., Hendrix, R., Linsley, P. S., Hathcock, K. S., Modes, R. J., Lowry, R. P. and Pearson, T. C. 1994. Regulation of immuno-stimulatory function and co-stimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152:5208.
14. Liu, Y. J., Barthelemy, C., de Bouteiller, O., Arpin, C., Durand, I. and Banchereau. J. 1995. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 2:239.
15. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Modes, J. 1994. Comparative analysis of B7-1 and B7-2 co-stimulatory ligands: expression and function. J. Exp. Med. 180:631.
16. Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F. and Nadler, L. M. 1989. B7, a new member of the Ig superfamiliy with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
17. Parra, E., Varga, M., Hedlund, G., Kalland, T. and Dohlsten, M. 1997. Co-stimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding. Mol. Cell. Biol. 17:1314.
18. h2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
19. Sperling, A. I. and Bluestone, J. A. 1996. The complexities of T-cell co-stimulation: CD28 and beyond, Immunol. Rev. 153:155.
20. Lanier, L. L., O'Fallon, S., Somoza, C., Phillips, J. H., Linsley, P. S., Okumura, K., Ito, D. and Azuma, M. 1995. CD80 (B7) and CD86 (B70) provide similar co-stimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
21. + T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-kappa B transcription factors. J. Immunol. 155:1132.
22. + T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles J. Immunol. 153:2479.
23. Lando, P. A., Olsson, C., Kalland, T., Newton, D., Kotb, M. and Dohlsten, M. 1996. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. J. Immunol. 157:2857.
24. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C. and Tepper, M. A. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
25. Björk, P., Jonsson, U., Svedberg, H., Larsson, K., Lind, P., Dillner, J., Hedlund, G., Dohlsten, M. and Kalland, T. 1993. Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody. J. Biol. Chem. 268:24232.
26. Dohlsten, M., Abrahamsén, L., Björk, P., Lando, P. A., Hedlund, G., Forsberg, G., Brodin, T., Gascoigne, N. R. J., Förberg, C., Lind, P. and Kalland, T. 1994. Monoclonal antibody-superantigen fusion proteins; tumor specific agents for T cell based tumor therapy. Proc. Natl Acad. Sci. USA 91:8945.
27. Hedlund, G., Dohlsten, M., Herrmann, T., Buell, G., Lando, P. A., Segrén, S., Schrimsher, J., MacDonald, H. R., Sjögren, H. O. and Kalland, T. 1991. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J. Immunol. 147:4082.
28. Dohlsten, M., Hedlund, G., Segrén, S., Lando, P. A., Herrmann. T., Kelly, A. P. and Kalland, T. 1991. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. Eur. J. Immunol. 21:1229.
29. + T-cell subsets. Scand. J. Immunol. 36:243.
30. Granelli-Piperno, A. and Nolan, P. 1991. Nuclear transcription factors that bind to elements of the IL-2 promoter. J. Immunol. 147:2734.
31. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L. and Somoza, C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
32. Miller, A. D. and Rosman, G. J. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980.
33. van de Griend, R. J., Giphart, M. J., van Krimpen, B. A. and Bolhuis, R. L. 1984. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies. J. Immunol. 133:1222.
34. Lando, P. A., Dohlsten, M., Hedlund, G., Brodin, T., Sansom, D. and Kalland, T. 1993. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity. Immunology 80:236.
35. Rincon, M. and Flavell, R. A. 1994. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO. J. 13:4370.
36. Comoli, P., Montagna, D., Moretta, A., Zecca, M., Locatelli, F. and Maccario, R. 1995. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. J. Immunol. 155:5506.
37. Caux, C., Vanbervliet, B., Massacrier, C., Azuma, M., Okumura., K., Lanier, L. L. and Banchereau, J. 1994. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180:184.
38. Zhang, Y., van Neerven, R. J. J., van Gool, S. W., Coorevits, L., de Boer M. and Ceuppens, J. L. 1997. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses. Int. Immunol. 9:1095.
39. Durand, D. B., Shaw, J., Bush, M. R., Replogie, R. E., Belagaje, R. and Crabtree, G. R. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715.
40. Go, C. and Miller, J. 1992. Differential induction of transcription factors regulate the interleukin 2 gene during anergy, induction and restimulation. J. Exp. Med. 175:1327.
41. Yi-qun, Z., van Neerven, J., Kasran, A., de Boer, M. and Ceuppens, J. 1996. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int. Immunol. 8:37.
42. Muraille, E., Devos, S., Thielemans, K., Urbain, J., Moser, M. and Leo, O. 1996. Co-stimulation regulates the kinetics of interleukin-2 response to bacterial superantigens. Immunology 89:245.
43. Masten, B. J., Yates, J. L., Pollard-Koga, A. M. and Lipscomb, M. F. 1997. Characterization of accessory molecules in murine lung dendritic cell function: roles for CD80, CD86, CD54, and CD40L. Am. J. Respir. Cell. Mol. Biol. 16:335.
44. Linsley, P., Greene, J., Brady, W., Bajorath, J., Ledbetter, J. and Peach, R. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
45. Lenschow, D., Walunas, T and Bluestone, J. 1996. CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14:233.
46. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X, Y., Rennert, P. D., Gray, G. S., Gribben, J. G. and Nadler, L. M. 1995. B7-1 and B7-2 do not deliver identical co-stimulatory signals, since B7-2 but not B7-1 preferentially co-stimulates the initial production of IL-4. Immunity 2:523.
47. Schreiber, S. L. and Crabtree, G. R. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136.
48. Sen, R. and Baltimore, D. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705.
49. Shaw, J. P., Utz, P. J., Durand, D. B., Toole, J. J., Emmel, E. A. and Crabtree, G. R. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202.
50. Fraser, J. Irving, D., B. A., Crabtree, G. R. and Weiss, A. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313.
51. Sugamura, K., Takeshita, T., Asao, H., Kumaki, S., Ohbo, K., Ohtani, K. and Nakamura, M. 1992. The IL-2/IL-2 receptor system: involvement of a novel receptor subunit, gamma chain, in growth signal transduction. J. Exp. Med. 168:231.
52. Civil, A., Geerts, M., Aarden, L. and Verweij, C. 1992. Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signals. Eur. J. Immunol. 22:3041.
53. ras and calcineurin synergize to regulate the nuclear factor of activated T cells. J. Exp. Med. 178:1517.
54. Rao, A. 1994. NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 15:274.
55. Majumdar, G. E., Beacney, H., Tomai, M. and Kotb, M. 1990. Differential signal requirements in T-cell activation by mitogen and superantigen. Cell. Signal. 2:21.